Coloplast A/S (OTCMKTS:CLPBY) Issues Earnings Results, Beats Expectations By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) released its quarterly earnings results on Tuesday. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01, Zacks reports. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%.

Coloplast A/S Stock Performance

Shares of OTCMKTS CLPBY traded up $0.06 during midday trading on Tuesday, hitting $6.39. 19,355 shares of the company’s stock were exchanged, compared to its average volume of 584,827. The firm has a market cap of $14.39 billion, a P/E ratio of 23.65, a PEG ratio of 2.03 and a beta of 0.15. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81. Coloplast A/S has a twelve month low of $6.10 and a twelve month high of $10.03. The stock’s 50 day moving average price is $6.76 and its 200-day moving average price is $8.00.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CLPBY. The Goldman Sachs Group lowered Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a report on Wednesday, January 28th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.